- Home
- INM vs GLMD Comparison
INM vs GLMD Comparison
Compare INM & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- GLMD
- Stock Information
- Founded
- INM 1981
- GLMD 2000
- Country
- INM Canada
- GLMD Israel
- Employees
- INM N/A
- GLMD N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- GLMD Health Care
- Exchange
- INM Nasdaq
- GLMD Nasdaq
- Market Cap
- INM 3.2M
- GLMD 3.0M
- IPO Year
- INM N/A
- GLMD 2014
- Fundamental
- Price
- INM $3.05
- GLMD $1.78
- Analyst Decision
- INM
- GLMD Hold
- Analyst Count
- INM 0
- GLMD 1
- Target Price
- INM N/A
- GLMD N/A
- AVG Volume (30 Days)
- INM 9.5M
- GLMD 356.1K
- Earning Date
- INM 05-12-2025
- GLMD 05-22-2025
- Dividend Yield
- INM N/A
- GLMD N/A
- EPS Growth
- INM N/A
- GLMD N/A
- EPS
- INM N/A
- GLMD N/A
- Revenue
- INM $4,920,990.00
- GLMD N/A
- Revenue This Year
- INM N/A
- GLMD N/A
- Revenue Next Year
- INM N/A
- GLMD N/A
- P/E Ratio
- INM N/A
- GLMD N/A
- Revenue Growth
- INM N/A
- GLMD N/A
- 52 Week Low
- INM $1.72
- GLMD $1.15
- 52 Week High
- INM $15.70
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- INM 51.86
- GLMD 61.10
- Support Level
- INM $3.32
- GLMD $1.63
- Resistance Level
- INM $5.50
- GLMD $1.91
- Average True Range (ATR)
- INM 0.37
- GLMD 0.12
- MACD
- INM 0.06
- GLMD 0.01
- Stochastic Oscillator
- INM 24.69
- GLMD 71.22
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.